DERM
DERM
NASDAQ · Pharmaceuticals

Journey Medical Corp

$6.37
-0.08 (-1.24%)
As of Aug 8, 2:02 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +145.8% upside
Low Target $10.95
Average Target $15.66
High Target $21.05
Current Price $6.37
Current
$6.37
Target
$15.66
$10.95 $15.66 avg $21.05
Scenario Analysis
Bear Case
$10.95
71.9%
Low target
Base Case
$15.66
+145.8%
Avg target
Bull Case
$21.05
+230.5%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$9.56
-33.3% from high
52-Week Low
$4.31
+47.8% from low
Target vs 52W High
$15.66
+63.9% vs high
Next Earnings Report
Aug 12, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.02
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%